What is the appropriate emergency department workup for a patient presenting with a severe migraine headache?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The emergency department workup for severe migraine should prioritize a thorough history and physical examination to rule out secondary causes of headache, followed by treatment with NSAIDs, such as ibuprofen or acetaminophen, and consideration of adding a triptan if necessary, as recommended by the American College of Physicians guideline 1. When evaluating a patient with severe migraine in the emergency department, it is essential to start with a comprehensive history and physical examination to identify any potential secondary causes of headache, such as meningitis or subarachnoid hemorrhage. Vital signs, neurological examination, and fundoscopic examination should be performed to assess the patient's overall condition. Some key points to consider in the workup and treatment of severe migraine include:

  • Ensuring the patient is using the appropriate dosage of NSAIDs or acetaminophen, and considering increasing the dosage if necessary, without exceeding the recommended maximum daily dose 1
  • Adding a triptan to an NSAID or acetaminophen if the patient does not achieve sufficient pain relief, taking into account individual patient preferences and factors such as route of administration and cost 1
  • Considering the use of CGRP antagonists-gepants or ergot alkaloid for moderate to severe acute episodic migraine headache in nonpregnant outpatient adults who do not tolerate or have inadequate response to combination therapy of a triptan and an NSAID or acetaminophen 1
  • Avoiding the use of opioids or butalbital for the treatment of acute episodic migraine due to the risk of medication overuse headache and dependence 1 In terms of specific treatment options, NSAIDs such as ibuprofen or acetaminophen should be considered as first-line treatment, with the addition of a triptan if necessary, as recommended by the American College of Physicians guideline 1. Additionally, antiemetics and neuroleptics may be used to manage nausea and vomiting, and IV magnesium sulfate, dexamethasone, and valproate sodium may be effective for patients with status migrainosus.

From the Research

Emergency Department Workup for Severe Migraine

  • The workup for severe migraine in the emergency department may involve neuroimaging, although the diagnostic yield is low, as found in a study published in 2022 2.
  • A study from 2022 also found that treatment of mild migraine was in accordance with current guidelines, but few patients with moderate or severe symptoms received recommended treatment 2.
  • Medications commonly prescribed for migraine in the emergency department include paracetamol, nonsteroidal anti-inflammatory drugs, metoclopramide, ondansetron, chlorpromazine, and prochlorperazine 2.

Treatment Options for Severe Migraine

  • A randomized open-label study from 2013 compared the efficacy and tolerability of intravenous valproic acid with intramuscular metoclopramide + subcutaneous sumatriptan for prolonged acute migraine, and found that intravenous valproic acid was more effective during the first 2 hours 3.
  • Other studies have evaluated the effectiveness of various medications for migraine prophylaxis, including propranolol, timolol, amitriptyline, divalproex, sodium valproate, and topiramate as first-line agents 4, 5, 6.
  • The choice of prophylactic medication depends on efficacy, co-morbidity, side effects, availability, and cost, as well as patient-specific factors 5, 6.

Investigation and Management Patterns

  • A study from 2022 found that most patients with migraine had previously diagnosed migraine (77.7%), and that neuroimaging was performed in 25.9% of patients, with a very low diagnostic yield or significant findings (0.07%) 2.
  • The same study found that treatment of mild migraine was in accordance with current guidelines, but few patients with moderate or severe symptoms received recommended treatment, suggesting a need for improved compliance with existing management best practices 2.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Medications for migraine prophylaxis.

American family physician, 2006

Research

Treatment of migraine with prophylactic drugs.

Expert opinion on pharmacotherapy, 2008

Research

Migraine: prophylactic treatment.

The Journal of the Association of Physicians of India, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.